13F HOLDINGS REPORT
venBio Partners LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0000905148-23-001445
Total Value
$352.7M
Positions
8
Other Managers
0
Confidential Omitted
No
Holdings (8)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | RAYZEBIO INC | 75525N107 | 5,158,162 | $114.5M | 32.47% |
| 2 | PHARVARIS N V | PHVS | 4,264,672 | $89.0M | 25.24% |
| 3 | ALX ONCOLOGY HLDGS INC | ALXO | 9,699,925 | $46.6M | 13.20% |
| 4 | ACELYRIN INC | 00445A100 | 3,852,470 | $39.2M | 11.11% |
| 5 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 1,035,396 | $33.9M | 9.62% |
| 6 | VENTYX BIOSCIENCES INC | 92332V107 | 758,800 | $26.4M | 7.47% |
| 7 | ELEVATION ONCOLOGY INC | 28623U101 | 2,914,255 | $1.9M | 0.55% |
| 8 | IMPEL PHARMACEUTICALS INC | 45258K109 | 2,759,791 | $1.2M | 0.34% |